Life Sciences Report

Investment in digital health reached $4.7 billion in 2017

Digital Health 2018: Trends, Opportunities and Outlook

Telehealth, Telemedicine, Remote Patient Monitoring, mHealth, Health Analytics, Consumer Genetic Testing, Digital Therapeutics, Digiceuticals, Diabetes Management and Smart Home as a Carer

Digital health promises to change the face of healthcare. Reflecting this is growing interest in the digital health space, as evidenced by a substantial $4.7 billion being invested in 2017. Digital health also took prominence in the JP Morgan Healthcare Conference in January 2018, illustrating its growing importance - but it is not limited to strictly the healthcare space. CES 2018 also saw digital health having a substantial presence marking a new age of patient-centric healthcare.
The Rise of Digital Health
Digital health is a convoluted and complex field, much of which is made up of technologies and services that enable healthcare outside of traditional clinical settings. It follows a global trend in the healthcare industry of decentralization to alleviate overburdened hospitals and clinics. Coupled with escalating healthcare costs, shrinking profit margins and ageing populations suffering with chronic conditions, digital health offers a solution to these problems for all players in the space including patients, providers and payers. In fact, it presents such an alluring and lucrative opportunity that companies not previously in the healthcare space are making significant investments and moves to do so. Big tech companies such as Amazon, Apple and Alphabet also used January 2018 to announce their endeavours into the digital health space, impacting the price of stocks in the healthcare market.
Big Tech Threatens to Disrupt the Healthcare Industry (Source: IDTechEx Report on Digital Health 2018: Trends, Opportunities and Outlook)
Source: IDTechEx. Image included in Sample Pages
Numerous Factors are Encouraging the Rise of Digital Health
The time is ripe for digital health due to the combination of a number of factors. These include changing population demographics, such as ageing populations with increasing prevalence of chronic diseases, as well as current and upcoming changes to regulations and reimbursements which mean that the route to market and take-up of digital health services and technologies is more likely in 2018 and beyond.
Factors Encouraging the Rise of Digital Health (Source: IDTechEx Report on Digital Health 2018: Trends, Opportunities and Outlook)
Source: IDTechEx. Image included in Sample Pages
Disruption to Pharma is Inevitable
By whichever name it comes under, whether that's digiceuticals, digital therapeutics or software-as-a-drug, this idea of software replacing drugs is a worry for large, established pharmaceutical companies. Coupled with the changing landscape of healthcare which is moving away from treating patients and towards a model of preventative care and a move from fee-based to value-based services, big pharma is being disrupted and digital health threatens to cause even more turbulence.
The Wide Scope of Digital Health
This report acts as a primer to the digital health space, providing a detailed overview of the ecosystem and offering insights into the key trends, opportunities and outlooks for all aspects of digital health, including:
  • Telehealth and telemedicine: the provision of remote clinical or non-clinical services such as doctors visits through video calls e.g. Remote digital examinations for cardiac conditions through measuring heart rate and blood pressure and having a virtual physician meeting,
  • Remote patient monitoring: the remote monitoring of individuals to collect information through wearable sensors outside of a clinical settings e.g. smart watches collecting information on blood pressure.
  • Digital therapeutics / digiceuticals / software-as-a-drug: using software such as mobile phone apps to diagnose, treat and monitor patients e.g. a mobile app prescribed to treat PTSD.
  • Consumer genetic testing: describes the use of genome sequencing on consumer samples to reveal details about an individuals' genetic make-up which may impact their health e.g. using a cheek swab to determine whether you are likely to be predisposed to particular vitamin deficiencies or whether you are potentially lactose intolerant.
  • Diabetes management: chronic diseases such as diabetes present a substantial market for digital health e.g. continuous or flash glucose monitors which are wearable or non-invasive.
  • Smart home as a carer: lower costs and sizes of sensors, and better connectivity and networks along with ageing and diseased populations mean that fitting sensors into the home is becoming a reality allowing decentralized healthcare e.g. sensors which alert carers in case of an emergency.
Analyst access from IDTechEx
All report purchases include up to 30 minutes telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.
Further information
If you have any questions about this report, please do not hesitate to contact our report team at or call one of our sales managers:

Americas: +1 617 577 7890
Europe: +44 1223 812300
Korea: +82 31 263 7890
China: +86 158 5036 8392
Taiwan: +886 (0)9 3999 9792
Rest of Asia: +81 90 1704 1184
Table of Contents
1.1.The Scope of Digital Health
1.2.Relevant Reports from IDTechEx
1.3.$4.7 Billion Poured into Digital Health in 2017
1.4.Changing Demographics Require Healthcare Reforms
1.5.Global Healthcare Spending is Rising
1.6.Factors Encouraging the Rise of Digital Health
1.7.Enabling Technologies for Digital Health
1.8.Towards a Model of Value-Based Healthcare
1.9.Effective Use of Resources Enabling Cost Efficiency
1.10.Mobile Health and the Quantified Self
1.11.The Future of Healthcare is Consumer-Led
1.12.Big Tech Threatens to Disrupt the Healthcare Industry
1.13.Prevention is the Best Cure
1.14.The Move Towards Personalized Medicine
1.15.Pharma is Struggling, and Disruption is Inevitable
1.16.Consolidating and Collaborating to Survive and Thrive
1.17.Reimbursement Changes: A Pivotal Moment for Digital Health
1.18.Health Policy and Regulations are Complex and Uncertain
1.19.Telehealth and Telemedicine are Poised for Take-Off
1.20.Remote Patient Monitoring is Changing the Face of Healthcare
1.21.Digital Therapeutics - The Next Step for mHealth?
1.22.The Rise of Direct-to-Consumer Genetic Testing
1.23.Monetizing Genomic Testing
1.24.Chronic Diseases are Easy Initial Targets for Digital Health
1.25.Sensors in Smart Homes: Decentralization of Healthcare
1.26.With Big Data Comes Big Questions on Data Security
1.27.Global Challenges in Implementing Digital Health
1.28.Outlook for Digital Health: Quality, Outcomes and Value are Key
2.1.The Scope of Digital Health
2.2.Digital Health Definitions
2.3.Changing Demographics Require Healthcare Reforms
2.4.Global Healthcare Spending is Rising
2.5.Margins are Being Squeezed in Healthcare
2.6.Big Tech Players are Moving into Healthcare
2.7.Trouble for Traditional Healthcare?
2.8.From Fee-for-Service to Value-Based Purchasing
2.9.Big Pharma is Struggling
2.10.Digital Disruptors & Big Pharma: A Match Made in Heaven?
2.11.The Future for Pharma
2.12.Mobile Health is Becoming the Norm
2.13.Apps are Moving Towards Voice
2.14.A Move to Precision/Personalized Medicine
2.15.Biosensors are Moving to the Point-of-Care
2.16.Sensors in Wearable Medical devices: Volumes
2.17.Market Outlook: Wrist-Worn Fitness Trackers
2.18.Consumer-Driven, Patient Centred Healthcare
2.19.Challenges in Adopting Digital Technology
2.20.Regulation of Software as a Medical Device
2.21.The Security of Data is a Critical Issue
2.22.Security Risks for Medical Devices
2.23.The P4 Healthcare Model
2.24.The Emergence of a P4 Healthcare System
2.25.Enabling Technologies: 5G
2.26.Access to High Quality Broadband
2.27.Enabling Technologies: IoT
2.28.Enabling Technologies: Artificial Intelligence and Machine Learning
2.29.Can AI Replace Your Doctor?
2.30.Enabling Technologies: VR, AR and MR
3.1.Defining Telehealth and Telemedicine
3.2.The History of Telehealth and Telemedicine
3.3.Telehealth Encompasses a Range of Services
3.4.There are Numerous Types of Telemedicine
3.5.The Key Services Models for Telehealth
3.6.Use Cases for Telehealth and Telemedicine
3.7.Benefits of Telehealth and Telemedicine
3.8.Challenges in Telehealth and Telemedicine
3.9.Is Telehealth a Cost-Effective Solution?
3.10.Payers, Providers, Consumers and Clinicians Benefit
3.11.The Growing Network of Care
3.12.Doctors Require Better Ways of Communication
3.15.American Well
3.16.Key American Well Partnerships
3.17.Smartphones Become the Tool for Doctors
3.18.Driving the Take-Up of Telemedicine
3.19.Recent Changes to Reimbursement of Telehealth
3.20.Room to Improve and Mature
3.21.The Next-Generation of Telemedicine
3.22.The Future for Telehealth and Telemedicine I
3.23.The Future for Telehealth and Telemedicine II
4.1.Remote Patient Monitoring: Measurements and Applications
4.2.Components of a Remote Monitoring System
4.3.The Benefits of Remote Patient Monitoring
4.4.Remote Patient Monitoring in Hospitals and the Home
4.5.Remote Patient Monitoring Solutions in the Home
4.6.Remote Patient Monitoring Solutions in Hospitals
4.7.Evolution of the Stethoscope into the Digital Realm
4.8.iHealth Labs
4.15.Remote Patient Monitoring in Clinical Trials
4.16.Apple Enters the Electronic Health Record Market
4.17.The Benefits of Remote Patient Monitoring for Payers
4.18.UnitedHealthcare Motion: US
4.19.Momentum Multiple: South Africa
4.20.Vitality: UK
4.21.Regulation of Remote Patient Monitoring
4.22.Is Remote Patient Monitoring Really Helpful?
4.23.The Outlook for Remote Patient Monitoring
5.1.Digital Therapeutics: App Based Healthcare
5.2.The Rationale Behind Digital Therapeutics (DTx)
5.3.Digital Therapeutics for Chronic Conditions Poised for Success
5.4.Insurers are Investing in Digital Therapeutics
5.5.Regulation of Digital Therapeutics
5.6.Difficulties in Realising the Potential of Digital Therapeutics
5.7.Digital Therapeutics Alliance
5.8.Better Therapeutics
5.9.PEAR Therapeutics
5.12.Akili Interactive
5.14.Glooko-Novo Nordisk in Diabetes Care
5.15.Diabetes Partnerships are Proliferating
5.16.Propeller-Novartis in Asthma Care
5.18.The Outlook for Digital Therapeutics
6.1.The Central Dogma: DNA, RNA and Proteins
6.2.What is Direct-to-Consumer Genetic Testing?
6.3.Genetic Variations: What Are We Testing For?
6.4.Regulation of Direct-to-Consumer Genetic Testing
6.5.The Rise of Direct-to-Consumer Genetic Testing
6.6.Genetic Data, Privacy Concerns and a Lack of Trust
6.7.Monetizing Genomic Testing
6.8.The Emergence of Genomics Analysis Companies
6.9.Rent-Out Your DNA Data
6.10.Not All Data is Created Equal
6.11.AI Driven Genomics and Drug Development
6.12.Alexa-Powered AI Genomics Platform
6.13.Using Genomics to Diagnose NHS Patients
6.16.Atlas Biomed Group
7.1.Diabetes is an Early Adopter of Digital Healthcare Initiatives
7.2.Market Segmentation in Diabetes Care
7.3.Decreasing Profitability Means Change for Manufacturers
7.4.Glucose Monitoring Companies See the Value in Data
7.5.Not All Biological Samples are Ideal for Clinical Monitoring
7.6.Remote Glucose Monitors
7.7.Key Players in Wearable ISF Glucose Monitors
7.8.Continuous vs Flash Glucose Monitoring
7.9.People with Type 1 Diabetes are Transitioning to Newer Methods
7.10.Key Players in Implantable Glucose Monitoring
7.11.Non-Invasive Glucose Monitoring
7.12.Strong Growth is Expected in Wearable, Less in Implantable
7.13.Disposable and Wearables are Moving in Separate Directions
7.15.Abbott Libre
7.17.Market Forecast: Glucose Monitoring
7.18.Diabetes Apps
7.20.Amazon Tackle Diabetes Care
7.21.Alexa Diabetes Challenge Finalists
7.22.Sugarpod Champions Diabetes Care
7.23.Smart Pen Platform Preventing Missed Doses
7.24.Pump Security is a Key Issue
8.1.Smart Home as a Carer Becomes Increasingly Important with Ageing Populations
8.2.Bringing Healthcare into the Home by Fitting Sensors
8.3.Medical Asset Tracking Allows for More Productive Refilling of Medicines and Vital Equipment in the Home
8.4.Philips Smart Home as a Carer Ecosystem is Able to Alert Carers in Case of an Emergency
8.5.Home Asthma Care
8.6.Dr Alexa
8.7.Digital Health Apps Using Amazon Alexa
8.8.Health Information at Home Through Voice Technology
8.9.Hospitals Look to Amazon Alexa
9.1.Cityzen Sciences
9.2.Companion Medical
9.3.DexCom Inc
9.4.Emperra Diabetes Care
9.5.Gait Up
9.8.Hivox Biotek
9.10.Novarum DX

Ordering Information

-Electronic (1-5 users)$5,995.00
-Electronic (6-10 users)$8,495.00
-Electronic and 1 Hardcopy (1-5 users)$6,495.00
-Electronic and 1 Hardcopy (6-10 users)$8,995.00
Click here to enquire about additional licenses.
If you are a reseller/distributor please contact us before ordering.
お問合せ、見積および請求書が必要な方は までご連絡ください。

Subscription Enquiry